KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Preferred Dividend Payments (2016 - 2018)

Neogenomics (NEO) has disclosed Preferred Dividend Payments for 3 consecutive years, with $3.7 million as the latest value for Q4 2018.

  • For the quarter ending Q4 2018, Preferred Dividend Payments rose 36.64% year-over-year to $3.7 million, compared with a TTM value of $3.7 million through Sep 2019, down 43.12%, and an annual FY2018 reading of $5.6 million, down 46.65% over the prior year.
  • Preferred Dividend Payments was $3.7 million for Q4 2018 at Neogenomics, up from $2.8 million in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $5.6 million in Q1 2016 and bottomed at $894000.0 in Q1 2017.
  • Average Preferred Dividend Payments over 3 years is $3.0 million, with a median of $2.7 million recorded in 2017.
  • Peak annual rise in Preferred Dividend Payments hit 105.42% in 2017, while the deepest fall reached 83.94% in 2017.
  • Year by year, Preferred Dividend Payments stood at $1.3 million in 2016, then soared by 105.42% to $2.7 million in 2017, then surged by 36.64% to $3.7 million in 2018.
  • Business Quant data shows Preferred Dividend Payments for NEO at $3.7 million in Q4 2018, $2.8 million in Q2 2018, and $1.0 million in Q1 2018.